Red Cell

Red Cell Partners and General Catalyst Co-Develop Andesite to Advance Cybersecurity for Analysts

Retrieved on: 
Tuesday, April 9, 2024

Red Cell Partners and General Catalyst today announced the public launch of Andesite AI (“Andesite”), a cybersecurity company dedicated to delivering cutting-edge technology to overburdened cybersecurity teams.

Key Points: 
  • Red Cell Partners and General Catalyst today announced the public launch of Andesite AI (“Andesite”), a cybersecurity company dedicated to delivering cutting-edge technology to overburdened cybersecurity teams.
  • Co-developed by Red Cell and General Catalyst, Andesite has built an advanced AI security analytics platform to empower both private- and public-sector cyber analysts to defend against advanced persistent threats (APTs).
  • Andesite is the latest company to launch under Red Cell’s newly formed Cyber Practice, led by George Barnes, a former Deputy Director of the National Security Agency (NSA).
  • "I partnered with General Catalyst to help bring global resilience to our most critical industries.

Former Assistant Secretary of Defense for Readiness Veronica B. Daigle Joins Red Cell Partners as President of its National Security Practice

Retrieved on: 
Wednesday, March 20, 2024

Red Cell Partners, an incubation firm that builds and invests in technology-led companies that are bringing revolutionary advancements to market in national security, cyber, and healthcare, today announced that Veronica B. Daigle, the former Assistant Secretary of Defense for Readiness, has joined the firm as Partner and National Security Practice President.

Key Points: 
  • Red Cell Partners, an incubation firm that builds and invests in technology-led companies that are bringing revolutionary advancements to market in national security, cyber, and healthcare, today announced that Veronica B. Daigle, the former Assistant Secretary of Defense for Readiness, has joined the firm as Partner and National Security Practice President.
  • In her role, Daigle will oversee Red Cell’s national security strategy across incubation and investment verticals.
  • She will recruit and partner with entrepreneurs to create technology-enabled solutions for known or emergent market gaps with a focus on maximizing America’s defense capabilities.
  • “Coming from a family with strong ties to the military, I’ve always had a deep interest in national security,” Daigle said.

Red Cell Partners Launches Eyris to Revolutionize Data Protection and Cybersecurity

Retrieved on: 
Wednesday, March 13, 2024

Red Cell Partners (Red Cell), an incubation firm building rapidly scalable, technology-led companies that are bringing advancements to market in national security, cyber, and healthcare, has announced $3 million in pre-seed funding for Eyris, a digital infrastructure platform created to provide cybersecurity, secure communications, and data protection.

Key Points: 
  • Red Cell Partners (Red Cell), an incubation firm building rapidly scalable, technology-led companies that are bringing advancements to market in national security, cyber, and healthcare, has announced $3 million in pre-seed funding for Eyris, a digital infrastructure platform created to provide cybersecurity, secure communications, and data protection.
  • Since Eyris is cloud- and encryption-agnostic, it can work with various cloud providers and encryption methods, tailoring its solutions to customer needs.
  • Eyris, which emerged out of stealth in 2023, was co-founded by Kevin Keaton, a U.S. Army veteran and former Chief of Innovation for the National Security Agency (NSA).
  • “We bring revolutionary advancements in cybersecurity, data protection, and resiliency to national defense and beyond.”

George C. Barnes, Former Deputy Director of the National Security Agency, Joins Red Cell Partners to Lead Newly Formed Cyber Practice

Retrieved on: 
Wednesday, January 17, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240112829488/en/
    George Barnes - President of Cyber at Red Cell Partners (Photo: Business Wire)
    In his role, Barnes will oversee Red Cell’s cyber strategy across incubation and investment verticals.
  • “With George at the helm, the Red Cell Cyber Practice will drive innovation to strengthen cybersecurity and resiliency for government and commercial clients in a highly contested, network-centric world.
  • We are honored to have him part of the Red Cell family.”
    Prior to joining Red Cell, Barnes served as the Deputy Director and senior civilian leader of the U.S. National Security Agency (2017-2023).
  • I am excited to lead the new Red Cell Cyber Practice and partner with founders who are driving meaningful change to preserve the integrity of networks and advance national security.”

Red Cell Partners Launches Savoy Life, a Virtual Healthcare Platform for Long-Term Care

Retrieved on: 
Tuesday, September 26, 2023

Red Cell Partners (Red Cell), an incubation firm building rapidly scalable, technology-led companies that are bringing revolutionary advancements to market in national security and healthcare, today announced $3 million in pre-seed funding for Savoy Life, a virtual care coordination and delivery platform created to improve care quality and access for seniors and adults with disabilities living in residential community care facilities.

Key Points: 
  • Red Cell Partners (Red Cell), an incubation firm building rapidly scalable, technology-led companies that are bringing revolutionary advancements to market in national security and healthcare, today announced $3 million in pre-seed funding for Savoy Life, a virtual care coordination and delivery platform created to improve care quality and access for seniors and adults with disabilities living in residential community care facilities.
  • Savoy Life does this via a suite of offerings - all delivered virtually – aimed at elevating the standard of care inside thousands of residential care communities across America.
  • Savoy Life was designed to address this root issue and to be the dependable health care partner that long-term care communities need.”
    The pre-seed funding from Red Cell Partners allows Savoy Life to launch its initial offerings, which include three distinct products designed to improve assisted-living operations and empower caregivers to deliver high-quality care.
  • “Through our virtual care platform, we will enable a new paradigm in long-term care where the baseline quality of life is significantly improved for seniors and disabled adults,” Emigh said.

Retired Vice Admiral Raquel “Rocky” C. Bono, Former Director of the Defense Health Agency, Joins Red Cell Partners as a Senior Advisor and the Board of TARA Mind

Retrieved on: 
Thursday, June 1, 2023

Red Cell Partners (Red Cell), an incubation firm building technology-centered companies that are bringing revolutionary advancements to market in national security and healthcare, today announced that Vice Admiral (Retired) Raquel “Rocky” C. Bono, MD, MBA, FACS, has joined as a Senior Advisor.

Key Points: 
  • Red Cell Partners (Red Cell), an incubation firm building technology-centered companies that are bringing revolutionary advancements to market in national security and healthcare, today announced that Vice Admiral (Retired) Raquel “Rocky” C. Bono, MD, MBA, FACS, has joined as a Senior Advisor.
  • Bono, who made history as the Navy’s first female medical officer to achieve the rank of three-star admiral, will also bring her decades of expertise to the Board of Red Cell portfolio company, TARA Mind .
  • “What we do in health and medicine provides the foundation for functional and robust economic systems and is therefore critical to national security.
  • To be part of an organization like Red Cell whose mission is so in line with my own personal and professional beliefs represents a rare opportunity.

Red Cell Partners Announces $3 Million in Pre-Seed Funding for Psychedelic Company TARA Mind

Retrieved on: 
Thursday, April 13, 2023

Red Cell Partners, an incubation firm building and investing in technology-led companies that bring revolutionary advancements to healthcare and national security, has announced $3 million in pre-seed funding for TARA Mind, a mental health company that enables safe and affordable access to psychedelic-assisted therapy (PAT).

Key Points: 
  • Red Cell Partners, an incubation firm building and investing in technology-led companies that bring revolutionary advancements to healthcare and national security, has announced $3 million in pre-seed funding for TARA Mind, a mental health company that enables safe and affordable access to psychedelic-assisted therapy (PAT).
  • The problem is a large and complicated one exacerbated by misaligned incentives, a global pandemic, and deep-rooted stigma surrounding psychedelics and other alternative therapies.
  • “Far too many people are being failed by our country’s outdated approach to mental health care,” said Red Cell CEO and TARA Mind Co-Founder, Grant Verstandig.
  • At TARA Mind, we aren’t being guided by ‘the buzz’ around psychedelics, nor are we chasing a quick profit from lingering loopholes in a post-COVID world.

Retired Admiral Bill Lescher, former Vice Chief of Naval Operations, Joins Red Cell Partners and DEFCON AI

Retrieved on: 
Tuesday, January 31, 2023

Red Cell Partners (Red Cell), an incubation firm building technology-focused companies that are bringing revolutionary advancements to market within the national security and healthcare arenas, today announced that Admiral (Retired) William K. Lescher, the 41st Vice Chief of Naval Operations, has joined as a Senior Advisor.

Key Points: 
  • Red Cell Partners (Red Cell), an incubation firm building technology-focused companies that are bringing revolutionary advancements to market within the national security and healthcare arenas, today announced that Admiral (Retired) William K. Lescher, the 41st Vice Chief of Naval Operations, has joined as a Senior Advisor.
  • In addition, Lescher has joined DEFCON AI (DEFCON), a Red Cell portfolio company building next-generation tools for the modern military mobility environment, as a Strategic Advisor.
  • View the full release here: https://www.businesswire.com/news/home/20230131005226/en/
    “The depth of experience and insight that Bill brings to Red Cell Partners and DEFCON AI cannot be overstated,” said Grant Verstandig, Red Cell Founder & CEO and DEFCON Co-Founder and Executive Chairman.
  • “I very much appreciate, and strongly align with, the values and mission focus of Red Cell and DEFCON,” Lescher said.

DEFCON AI Closes $5M Air Force SBIR Contract for Core Simulation and AI Capabilities

Retrieved on: 
Friday, December 16, 2022

This contract was awarded through Air Force Installations and Sustainment Center and Air Mobility Command to accelerate the transition from prototype to production code for DEFCON AIs operational-level logistics and mobility training software.

Key Points: 
  • This contract was awarded through Air Force Installations and Sustainment Center and Air Mobility Command to accelerate the transition from prototype to production code for DEFCON AIs operational-level logistics and mobility training software.
  • In June 2022, DEFCON AI was awarded the Department of the Air Force Phase II SBIR to support the initial development of the program.
  • Initial operational capabilities will be delivered to the Air Forces Air Mobility Command (AMC), a US Air Force major command and component of US Transportation Command, by the end of 2025.
  • DEFCON AI is building a hands-on, artificial intelligence enabled training and rehearsal software platform that contains a game-theory driven modeling and simulation environment.

Zephyr AI and MedStar Health Embark on an Ambitious Partnership to Enhance Predictive Analytic Capabilities for Chronic Disease

Retrieved on: 
Friday, November 4, 2022

Initially focused on type 2 diabetes (T2D), the partnership will leverage MedStar Healths T2D de-identified data sets and patient management expertise to refine Zephyr AIs predictive analytics Insights product.

Key Points: 
  • Initially focused on type 2 diabetes (T2D), the partnership will leverage MedStar Healths T2D de-identified data sets and patient management expertise to refine Zephyr AIs predictive analytics Insights product.
  • We are laser-focused on delivering results that improve the timeliness of T2D interventions and decrease devastating adverse health outcomes commonly associated with the chronic condition, such as end-stage chronic kidney disease, dialysis, foot ulcers, and amputations.
  • Together, Zephyr AI and MedStar Health can develop technology that brings the promise of precision medicine to chronic diseases and that complements our existing programs to improve outcomes and reduce costs for people with diabetes.
  • Zephyr AI is a high-growth healthcare technology company committed to radically reshaping traditional approaches to precision medicine.